Skip to main content
. 2020 May 28;9(6):1631. doi: 10.3390/jcm9061631

Figure 3.

Figure 3

Prevalence of statin therapy at the time of admission relative to the presence or absence of CAC and ASCVD risk in the primary prevention group. Data limited to the 179 patients for which ASCVD risk and statin therapy information were available. CAC—coronary artery calcification, ASCVD risk—atherosclerotic cardiovascular risk score by the Pooled Cohort Risk Calculator.